QR Code

Bictegravir/Emtricitabine/Tenofovir Alafenamide in Adults with HIV/HBV Coinfection: An Open-Label, Single-Arm, Safety and Efficacy Switch Study

Background: HIV and hepatitis B virus (HBV) coinfection has been associated with a higher risk of morbidity and mortality. HBV-active antiretroviral regimens have significantly improved the outcomes for coinfected people. Although bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) is safe...

Description complète

Enregistré dans:
Auteurs principaux: Helena Kwakwa, Jacqueline Bran, Julia Ruff, Salma Sharaf, Hyunuk Seung, Sunny Choe, Joel V. Chua
Format: Artigo
Langue:Inglês
Publié: MDPI AG 2025-03-01
Collection:Viruses
Sujets:
HIV
hepatitis B
HIV-HBV coinfection
bictegravir
tenofovir alafenamide
Accès en ligne:https://www.mdpi.com/1999-4915/17/4/510
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires